Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876429 · ClinicalTrials.gov registry record · NA
Optimizing the Safety of Inter-Hospital Transfer
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,658
- Enrollment target
NCT05876429 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,658 participants.
The verdict
NCT05876429, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,658 participants
- Enrollment target
Study Summary
This proposal aims to design, implement and rigorously evaluate a standardized accept note in a population of patients that have high frequency of IHT, including patients transferred to the general medical (GMS), cardiology and oncology services at a large tertiary care hospital. This study will improve scientific knowledge by quantifying the patient safety impact of an intervention to improve communication of essential clinical information during IHT. If shown effective, the results of this study can be used to improve clinical practice by establishing evidence-based communication guidelines for broad dissemination. We will also establish technical feasibility by successfully implementing this tool within our EHR (Epic, Verona, WI), allowing for feasible adoption and dissemination to other institutions with similar EHR capabilities. Lastly, we will address malpractice risk by investigating a strategic intervention aimed at reducing known contributors to patient harm during IHT, a high-risk transition in care that involves transfer of high-acuity patients between providers, settings and systems of care.
Interventions
- OTHER New Standardized Accept Note
- OTHER Existing Transfer Patient Admission Process
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,658 participants |
| Start Date | 2020-08-17 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05876429
The ClinicalTrials.gov registry entry for NCT05876429 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,658 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which New Standardized Accept Note is the first listed.
NCT05876429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05876429 about?
NCT05876429 is a clinical study titled "Optimizing the Safety of Inter-Hospital Transfer". This proposal aims to design, implement and rigorously evaluate a standardized accept note in a population of patients that have high frequency of IHT, including patients transferred to the general medical (GMS), cardiology and oncology services at a large tertiary care hospital. This study will imp...
What is the current status of trial NCT05876429?
This trial is currently completed. It is a NA study. The enrollment target is 1,658 participants. The study started on 2020-08-17. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05876429?
The interventions under investigation include: New Standardized Accept Note (OTHER), Existing Transfer Patient Admission Process (OTHER).
Who is sponsoring clinical trial NCT05876429?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.